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priate management. This study was performed to explore how different methods
stratify the risk of CVD and how the awareness of CVD risk impacts its manage-
ment in hypertensive patient. METHODS: A prospective, multi-center observa-
tional studywas conducted in hypertensive patients aged 40 years in Korea. CVD
risk was assessed using the clinical algorithm (the National Cholesterol Education
Program-Adult Treatment Panel III guideline) and carotid ultrasound (CUS). Physi-
cians’ CVD risk management patterns were assessed through chart review. Pa-
tients also completed a questionnaire before and 6months after CVD risk assess-
ment to determine self-reported behavioral changes. RESULTS: Among 294 (male
65%, 618 years), 14,9, 77.8 and 7.3% patients were determined to have low, mod-
erate and high CV risk by CUS and 49.0 and 51.0% patients were low and high risk
by clinical algorithm, respectively. Among 273 patients classified as having low-to-
moderate CV risk by the clinical algorithm, approximately half of patients (51%,
138/273) were redefined as high risk by CUS. For the high-risk comparing to the
low-risk patients based on CUS, physicians set more lowered target goals for the
management of hypertension (25.8 vs. 3.6% of physicians, P0.001), LDL-choles-
terol (51.6 vs. 23.6% of physicians, P0.001) and more changed the intensities of
anti-hypertensive agent (4.9 vs. 1.2% of physicians, P0.047). Patients reported
higher rates of smoking cessation, dietary changes (reduced dietary sodium), and
increased medication compliance at 6month comparing to the baseline (P0.05,
respectively). CONCLUSIONS: This study shows that there is a significant differ-
ence in CVD risk level between clinical algorithm and CUS. However, proactive
awareness of CV risk had major effects on physician and patient behaviors in CVD
risk management.
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THE BURDEN: A NEW APPROACH TO EVALUATING VENOUS INSUFFICIENCY
Taieb C
CREES PFSA, Boulogne, France
OBJECTIVES: Evaluating the burden of a disease is a new way of measuring its
impact on the lives of sufferers, as it takes into account all the problems caused by
the illness. The ABC-V questionnaire was created and published in 2010 (Phlebol-
ogy, 2010-25:280-285).METHODS: It was administered to a population under treat-
ment with phlebotonic drugs (Ruscus aculeatus, Hespéridine méthyl chalcone,
ascorbic acid) RESULTS: Sixty-five subjects were monitored for 56 days, average
age 4716.7, gender: 60% women, with an average BMI of 24.763,95. At inclusion
and before treatment, the burden score was 32.817.6. No difference was observed
according to gender (the male score was 33.6 20.2, the female 32.315.48 p0.4),
to age (35.2  12.4 in those older than 55 vs 31.1520.2 in the younger age braced
(p0.2); There was a difference, however, in the ABC-V score dependent on sport
activity: 36.05 vs 27,68(p0.02) On days 28 and 56, the burden score was 22.613.9
and 19.613.8 respectively. The burden is therefore observed to have significantly
and statistically reduced. The quantity of effect has been measured, and the bur-
den is 27% reduced on the day 28 and 40% on day 56. Aside from averages, a
reduction in burdenwas observed in nearly 93% of subjects. For 68% of subjects the
reduction was greater than 30% by the 56th day. Greater reduction of burden was
observed in subjects who took regular exercise, vs those who did not (41% vs 38%)
and under 50 vs over 50 (47% vs 31%) The scores that improved the most were:
treatment by GP (58%), daily life (52%) and psychological impact (54%)
CONCLUSIONS: The ABC-V burden questionnaire was created and validated in
2010 (psychometric and cognitive debriefing). This study has demonstrated and
confirmed its sensitivity to change. It is available in French, English, Italian and
Spanish.
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OBJECTIVES: Tests of exercise capacity and quality of life (QOL) questionnaires are
used to predict outcomes in heart failure (HF) patients. The short performance
physical battery (SPPB) and Ferrans and Power’s quality of life index (QLI) are sim-
ple, free tests commonly used in geriatric and oncology patients, but data on their
use in cardiovascular diseases is limited. We sought to assess their utility in ad-
vanced HF patients.METHODS: Ten patients with advanced HF scheduled for ven-
tricular assist device implant were enrolled in this prospective, observational
study. Multiple exercise capacity tests including maximal cardiopulmonary stress
testing (CPX), 6 minute walk (6MWT), shuttle walk test (SWT), and SPPB were per-
formed. Minnesota Living With Heart Failure (MLWHF) questionnaire, SF-36 v2™,
and QLI were administered. Cardiac output was measured non-invasively by acet-
ylene rebreathing. Data were reported in meanSD. Pairwise correlations were
calculated between exercise capacity tests and QOL questionnaires. RESULTS:
Mean age was 62.18.6 years. The mean CPX duration was 5.62.9 minutes and
CPX respiratory exchange ratio (RER) was 1.20.2. The 6MWTwas 290137m, SWT
distance was 16797 m, and SPPB score was 7.7  2.6. MLWHF score was 6915,
mean SF-36 Physical Component Score (PCS) was 3010, SF-36 Mental Component
Score was 4212, and QLI was 19.24. CPX maximal cardiac output was 5.83 at
rest and 8.45.9 L/min at peak exercise. SPPB score showed a trend towards posi-
tive correlation with 6MWT (r0.6, p0.06), SF-36 PCS (r0.55, p0.096) and a
negative correlation with MLWHF score (r -0.71, p0.01). QLI was positively cor-
related with CPX RER (r0.7, p0.05), 6MWT (r0.7, p0.005), SWT distance
(r0.79, p0.03), and SF-36 PCS (r0.7, p0.01). CONCLUSIONS: SPPB and QLI cor-
related well to more laborious and technically demanding exercise capacity tests
and generic QOL indices in advanced HF patients. Additional evaluation in a
broader population of heart failure patients is needed.
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OBJECTIVES: To compare clinicians’ and patients’ views of post-stroke spasticity
(PSS) symptoms and their impact on health-related quality of life (HRQoL).
METHODS: Interviews were conducted with 13 clinicians specializing in the treat-
ment of PSS. Emergent themes from these interviews were compared with the
findings from 6 patient focus groups involving 59 patients. RESULTS: Clinicians
described altered muscle tone and spasticity as distinct manifestations of upper
motor neuron syndrome but suggested that patients do not distinguish between
the two. Clinicians perceived patients to view spasticity as muscle tightness/stiff-
ness that affects limb positioning, posture, and function, with patient values and
coping strategies influencing the degree to which PSS impacts various domains of
their lives. Existing HRQoL measures were thought to be too general and to over-
look specific consequences associated with PSS. Patients described PSS in terms of
movement difficulties, and not muscle characteristics. Specifically, patients char-
acterized PSS as an inability to direct armmovements, position the hand, and grasp
objects in the upper limbs; and, as an inability to walk, maintain balance, and
minimize the risk of falls in the lower limbs. Ten HRQoL domains were found to
fully represent the effects of PSS on individual well being: symptom impact, phys-
ical function, activities of daily living, ambulation and mobility, ambulation risk,
social function, social support, loss of role function, appearance, and adaptive
resiliency. CONCLUSIONS: While clinicians and patients generally agreed on the
functional areas affected by PSS, clinicians tended to focus on diagnostic features
of excess muscle tonicity and spasm whereas patients concentrated on the com-
plex psychosocial effects of PSS - particularly the effects of disability on their sense
of self and personal relationships. An understanding and assessment of the com-
plex ways that PSS impacts patients’ lives has clinical relevance, particularly in
terms of screening for disabling PSS and treatment decisions.
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OBJECTIVES: To assess the effect of secondary preventive measures on the Health
Related Quality of Life (HRQoL) of myocardial infarction patients. METHODS: The
Medical Expenditure Panel Survey (MEPS) data from 2004 to 2008 were used to
conduct a retrospective longitudinal study which included adults  18 years with
myocardial infarction. The lifestyle modifications considered were smoking cessa-
tion, regular exercise and weight control. Pharmacotherapy was defined as the use
of aspirin, beta-blockers, statins and ACEI/ARBs. HRQoL was determined on the
basis of the SF-12 survey instrument. Two multiple linear regression models for
physical component summary (PCS) and mental component summary (MCS)
scores were conducted. The primary independent variables included the second-
ary preventive measures. The other predisposing, enabling and need variables
were identified based on the Andersen Behavior Model. A p-value of 0.05 was
considered to be statistically significant. RESULTS: Non-smokers had a signifi-
cantly better MCS score as compared to smokers (  2.88; CI: 0.90 – 4.85; p 
0.0053). Regular exercise was significantly associated with improvement in PCS
(  3.28; CI: 1.91 – 4.64; p  0.001) and MCS ( 1.83; CI: 0.23 – 3.42; p  0.0255)
scores whereas statin use was associated with an improvement in the MCS ( 
3.31; CI: 1.80 – 4.83; p  0.001). Use of ACE/ARB, beta-blocker or aspirin and normal
BMI, however, were not associated with improvement in HRQoL. CONCLUSIONS:
Lifestyle modifications like smoking cessation and exercise combined with regular
use of statins will help to improve HRQoL in patients with myocardial infarction.
Thus these measures should be aggressively promoted among myocardial infarc-
tion patients.
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COMPARISON OF CHARLSON, ELIXHAUSER AND HRQOL-CI RISK ADJUSTMENT
MEASURES IN PREDICTING HEALTH-RELATED QUALITY OF LIFE IN HEART
FAILURE PATIENTS
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OBJECTIVES: Comorbidities in Heart Failure (HF) patients are highly prevalent,
adversely affecting health related quality of life (HRQoL). Health related quality of
life-comorbidity index (HRQoL-CI) has been recently developed to risk adjust
HRQoL. The aim of this study was to compare the performance of HRQoL-CI with
Charlson and Elixhauser measures in predicting HRQoL in HF patients.METHODS:
The Medical Expenditure Panel Survey 2002-2008 data was used for this retrospec-
tive cross-sectional study. All adults (age 18 years) diagnosed with HF were in-
cluded in the study. International Classification of Disease, 9th Revision, Clinical
Modification and Clinical Classification Codes were used to identify HF patients, as
well as to construct different risk adjustment measures (D’hoore adaptation of
Charlson, Elixhauser and HRQoL-CI). HRQoL is documented in MEPS using short
form health survey (SF-12), with physical component score (PCS) and mental com-
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ponent score (MCS). Linear regression analysis was conducted with PCS and MCS
scores as dependent variables. Age, race and sex were included as baseline vari-
ables in all models while incorporating Charlson/D’hoore, Elixhauser, and HRQoL-
CI measures one at a time. Adjusted R2 were compared to assess the comparative
performances of risk-adjustment measures. RESULTS: The mean age was 6813
years, with 80.63% non-Hispanic whites. The average PCS and MCS for HF patients
were 45.5312.28 and 30.6411, respectively. HRQoL-CI (R2 0.2083) outperformed
Elixhauser (R2  0.1784) and Charlson/D’hoore (R2  0.1359) in predicting PCS.
Whereas, Elixhauser (R2  0.2184) had the best prediction of MCS compared to
HRQoL-CI (R2  0.1920) and Charlson/D’hoore (R2  0.0918). CONCLUSIONS: No
single comorbidity measure was best in predicting both PCS and MCS in HF pa-
tients; HRQoL-CI performed best in predicting PCS whereas Elixhauser measure
had the best prediction for MCS. Selection of risk adjustment method should be
based on the type of dimension used to evaluate HRQoL.
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OBJECTIVES: Re-hospitalization in heart failure (HF) patients is often the result of a
patient’s inability to adequately self-manage the condition. The objective of this
study is to determine if engaging inpatients in their care through technology is a
solution to improving patient self-management. METHODS: Two hundred seven-
ty-five patients with HF completed the HF interactive care plan while an inpatient
at one of six hospitals throughout the United States. A pretest posttest design was
used to evaluate a patient’s activation using the 13-item Patient Activation Mea-
sure (PAM-13), a valid and reliable instrument to measure a patient’s knowledge,
skill, and confidence to perform self-management of their chronic disease(s). After
completing the baseline PAM-13 following admission for a HF diagnosis, all 275
patients completed a self-paced set of interactive, educational modules through-
out their inpatient stay. These modules were typically completed 3 or 4 days after
admission, and then patients would complete the PAM-13 prior to discharge. The
PAM-13 places individuals into activation levels 1 (lowest) through 4 (highest)
based on an individual’s responses. RESULTS:A two-tailed t-test between baseline
and posttest scores of all participants showed a difference of 0.38 levels of activa-
tion (p .001). Because 168 of the 275 participants were at level 4 on the PAM-13 at
baseline, these individuals were removed and secondary analysis was performed
on the remaining 107 individuals. A two-tailed t-test revealed a difference of 1.05
levels of activation (p 0.001) after patients completed the interactive solution.
CONCLUSIONS: Providing education through an interactive solution while in the
hospital can improve activation scores in HF patients.
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OBJECTIVES: To determine blood pressure goal attainment levels and the factors
influencing them for a low-income, uninsured population with hypertension.
METHODS: A retrospective, cohort study was carried out by reviewing patient
charts at three different sites where patients from CareNet, a Toledo based safety-
net organization, received primary care. Eligible subjects were at least 18 years old
andwere CareNetmembers for aminimumduration of one year between the study
period of January 1, 2003 to December 31, 2008. Descriptive statistics were utilized
to determine goal attainment. Chi-square analysiswas used to determine variables
that had significantly different goal attainment. A binomial logistic regression
model was used to predict goal attainment. Goal attainment at the last recorded
visit served as the dependent variable and was classified as ‘Yes’ and ‘No’ (deter-
mined based on JNC-VII guidelines). Age, gender, race/ethnicity, BMI, tobacco use,
number of primary care visits, and pharmacotherapy treatment were used as pre-
dictor variables. RESULTS: A total of 269 patients were included in the final analy-
sis; 92 of these patients had diabetes while 177 didn’t have diabetes as co-morbid-
ity. The overall goal attainment was found to be 42.39% (n39) in the patients with
diabetes as co-morbidity and 60.45% (n107) among thememberswithout diabetes
as co-morbidity. Chi-square analysis found patients the variables of co-morbidity
(p0.05) and number of visits (p0.01) had significant differences in goal attain-
ment. Patients who had primary care visits between 6-10 times were found to be
significantly more likely (OR3.705; CI: 1.670-8.218) to attain goal when compared
to those who had just 1-5 visits. Notable trends were observed for other variables
(co-morbidity,race/ethnicity,tobacco) but the effect was not significant.
CONCLUSIONS: Goal attainment among CareNet members was found to be com-
parable to other studies and national statistics. Encouraging regular utilization of
primary care services may further improve the clinical outcomes for a population
utilizating a safety-net organization.
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OBJECTIVES: The role of patient- and hospital-level factors in predicting hospital
readmissions in the cardiovascular disease (CVD) setting is established, while the
contribution of community-level factors is less clear. We determine the contribu-
tion of county-level characteristics in predicting discharge and readmission
outcomes. METHODS: This retrospective analysis of hospital discharge data in-
cluded adult patients discharged alive from nonfederal acute care hospitals be-
tween 2000 and 2005. Merged hospital- and county- level data characterized the
admitting hospital in terms of quality of care and the patients’ residence county in
terms of income, crime, medical social services, and private transportation. Multi-
nomial logistic and logistic regression models examined, respectively, the likeli-
hood of 1) 3 discharge outcomes (home, unauthorized discharge, or furthermedical
care), and 2) 31-day same-hospital readmission. The likelihood ratio (LR) test and
Akaike Information Criterion (AIC) compared 3 models: Model 1: patient-level,
Model 2: patient- and hospital-level, and Model 3: patient-, hospital- and
county-level. RESULTS: Application of inclusion criteria resulted in 348,572 dis-
charges with a primary-listed discharge diagnosis of CVD. In the discharge out-
comes models, results from the LR tests that compared Model 2 to Model 1, and
Model 3 to Model 2 were statistically significant (2  773.38, p0.0001; 2 
1346.80, p0.0001), suggesting no data support for the implied restrictions in Mod-
els 1 and 2. The AIC forModels 1, 2, and 3were 309139, 308378, and 307047, favoring
Model 3. In the 31-day readmissionmodels, results from the LR tests that compared
Model 2 to Model 1, and Model 3 to Model 2 also were statistically significant (2 
34.73, p0.0001; 2  89.62, p0.0001). The AIC for Models 1, 2, and 3 were 144041,
144012, and 143931. CONCLUSIONS: Prediction models examining discharge and
readmissions outcomes can benefit from the inclusion of patient-, hospital, and
area (e.g. county) – level measures.
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OBJECTIVES: The aim of this research was to assess the quality of anticoagulation
therapy of patients with atrial fibrillation (AF) in a real life setting and to identify
the causal factors explaining anticoagulation quality deficits. Furthermore, clinical
consequences of suboptimal anticoagulation therapy (strokes, TIA, bleedings, em-
bolism, myocardial infarcts) are identified. METHODS: The INR values as well as
other clinical events concerning AF patients recruited into a prospective cohort
study (observation period of 12 month) were documented at every visit to the
treating doctor. Using the Rosendaal linear trend method, the time in therapeutic
range (TTR) of 2.0-3.0 was estimated. Additionally, the squared INR deviation was
investigated. To identify causes of INR-values below/above 2.0-3.0, a logistic regres-
sion on the basis of a TTR  60% as the dichotomous outcome was conducted.
RESULTS: For 525 patients from 71 study centers, at least two INR values were
available over a median observational period of 228.9 days (SD: 106.1 days). The
average TTR was 68.1 % (SD: 26.3 %). The average deviation of INR value from the
mean of the INR target range (2.5) was 0.44 (SD: 1.29). The results of themultivariate
regression (R20,179) show that themost important factors explaining a poor qual-
ity of anticoagulation therapy are bridging periods and patients self-reported need
of help regarding medication therapy without getting that help. In the group of
patients with a TTR60 %, the occurrence rate of clinical outcomes was higher
(p0.031) than in the group of patientswith a TTR60%.CONCLUSIONS: Labile INR
values lead to negative clinical outcomes. In order to improve the situation, the
main identified causes of poor anticoagulation quality should be addressed.
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OBJECTIVES: Atrial fibrillation (AF) has been identified by the Institute of Medicine
as one of the top research priorities for comparative effectiveness research, yet
there is limited methodological guidance on how to meet the evidentiary needs of
patients, clinicians, and payers. The Center for Medical Technology Policy (CMTP)
managed a stakeholder-driven process to develop an effectiveness guidance doc-
ument that issued guidance for trial designers on study design considerations to
best answer decision-makers’ needs in AF research. METHODS: The AF team re-
viewed the literature and conducted interviews with researchers, patients and
methodologists to scope the project needs. Open-question interviews were con-
ducted with 25 individuals from the clinical research, clinical practice, regulatory,
payer, professional organizations, and patient communities. An eight-person
multi-stakeholder technical working group worked in collaboration with CMTP
staff to establish and refine the recommendations. The methods recommenda-
tions were guided by the objective of achieving an acceptable balance across a
number of desirable dimensions, including internal validity, relevance, feasibility
and timeliness. The document was posted on CMTP’s website for a 30-day public
comment period as part of the broader dissemination and translation strategy.
RESULTS: The final recommendations provide guidance on the design of prospec-
tive studies in Atrial Fibrillation, rationale for their inclusion, specifics on imple-
mentation and data analysis/reporting considerations. The final list included five
research design recommendations, and three priority research areas that would
synergistically benefit stakeholders’ evidentiary needs and improve health
outcomes.CONCLUSIONS:Themeaningful engagement of patients, providers, and
decision makers to prioritize the questions and develop the methods to answer
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